查詢結果分析
相關文獻
- 以表面張力素治療早產兒呼吸窘迫症候群的概況
- Exogenous Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Two-Year Clinical Experience
- 以彩色杜卜勒超音波心圖評估呼吸窘迫早產新生兒補充表面張力素後心肺系統血流動力學變化
- 早產兒容易肺部不成熟
- 早產兒呼吸窘迫症候群之預防及治療
- Experiences with High-Frequency Oscillatory Ventilation in Premature Infants with Respiratory Distress Syndrome
- 慢性肺部疾病
- Risk Factors of Pulmonary Hemorrhage in Very-Low-Birth-Weight Infants: A Two-year Retrospective Study
- 兒童急性呼吸窘迫症候群與治療策略
- 早產兒呼吸窘迫症候群之預防與治療
頁籤選單縮合
題名 | Exogenous Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Two-Year Clinical Experience=表面張力素治療新生兒呼吸窘迫症: 兩年之臨床經驗 |
---|---|
作者 | 吳俊宏; 柯嘉音; Wu, Chun-hung; Kua, Ka-em; |
期刊 | 中華民國小兒科醫學會雜誌 |
出版日期 | 19971100、19971200 |
卷期 | 38:6 民86.11-12 |
頁次 | 頁463-467+500 |
分類號 | 417.517 |
語文 | eng |
關鍵詞 | 表面張力素; 呼吸窘迫症; 早產; Surfactant; Respiratory distress syndrome; Prematurity; |
英文摘要 | The purposes of this study were to gain local experience, to find out the efficacy and side effects of surfactant and to find out whether surfactant therapy will lower the mortality and morbidity of premature infants. From Nov. 1992 to Dec. 1994, there were 25 premature infants in his neonatal intensive care unit (NICU) enrolled in this study Another 25 premature infants with study group matched gestational age, weight, and Apgar score, who had been previously treated at this NICU from 1990 to 1992 served as control group. Modified bovine surfactant (Survanta, Abbot), 100 mg/Kg of surfactant phospholipid in 4 ml solution was administered intratracheally in four divided doses. The premature infants in the study group had prompt and sustained improvement in oxygenation. The improvement in FiO□ and arterial-to-alveolar oxygen tension ratio (a/APO□) were significantly different from the control infants from 12 hours post-treatment till the subsequent 48 hours after treatment. There was no difference in mortality rate between the two groups. There was no side effect noted from surfactant therapy. It was therefore concluded that modified bovine surfactant therapy is safe and effective for neonates with respiratory distress syndrome. A larger study is required to find out whether it lowers the mortality and morbidity in premature infants in Taiwan. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。